Management of Diabetic Retinopathy by Ayurveda– A case report
DOI:
https://doi.org/10.70066/jahm.v11i6.911Abstract
Diabetic retinopathy (DR) is a microvascular disorder occurring due to the long-term effects of diabetes mellitus. Diabetic retinopathy may lead to vision-threatening damage to the retina, eventually leading to blindness. Diabetic retinopathy is most common and serious complication of Diabetes and changes in the retina are observed by 10 years of Diabetes history or even earlier due to modified lifestyle in present era. There are many treatment Modalities mentioned in Morden Medicine but it is symptomatic and conservative therapy. Currently available conventional treatment for DR have certain limits. In Ayurveda DR can be compared with Madhumehajanya Timir .Ayurveda, the traditional system of Indian subcontinent hold huge number of remedies that can be useful in the treatment of diabetes and associated complications like diabetic retinopathy. To revalidate the actual efficacy of these formulations and treatment modalities in DR, this case study has been carried out. Remarkable results were observed in the form of improvement in all the signs and symptoms of the disease.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Dr Shital K. Baraiya
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.
